Global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032.
AI innovations, decentralized trials, and personalized therapies are driving the Global Clinical Trials Market, revolutionizing oncology, rare disease, and drug development efficiency.”
Global Clinical Trials Market Insights 2025-2032: AI-Enabled Clinical Trials, Decentralized Trial Models, Personalized Therapies, Oncology, Rare Disease, and Infectious Disease Research Trends
Global Clinical Trials Market is experiencing a transformative surge, driven by AI-enabled clinical trial designs, decentralized clinical trial models, and personalized therapies, with oncology, rare disease, and infectious disease trials leading innovation. Leading players such as IQVIA, PPD, Syneos Health, and Parexel leverage digital clinical trial platforms, advanced analytics, real-world evidence adoption, and decentralized trial solutions to optimize patient recruitment, accelerate clinical research efficiency, and unlock high-value opportunities in the global Clinical Trials Market.
